M.K. Zouaghi
Tunis El Manar University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M.K. Zouaghi.
Clinical Biochemistry | 2018
Mouna Bouksila; Wajih Kaabachi; Mehdi Mrad; Wided Smaoui; Elhem Cheour El Kateb; M.K. Zouaghi; Kamel Hamzaoui; Afef Bahlous
OBJECTIVES The aim of this study was to evaluate the association between two VDR SNPs FokI and BsmI and mineral status in ESRD patients. DESIGN AND METHODS Our case-control study included 100 patients with chronic renal failure in ESRD and 149 healthy subjects. We measured the serum Vitamin D levels and the serum intact PTH level by Electrochemiluminescence Technology (cobas E411 analyzer). We evaluated the serum FGF23 levels by indirect ELISA method. The genotyping of two VDR gene variants FokI and BsmI was carried out by PCR-RFLP technique. RESULTS In our study, the FokI TT genotype was associated with lower risk of ESRD development (OR = 0.176, Padj = 0.039). The difference in PTH and FGF23 levels between cases and controls was statistically significant. The expression of FokI CT genotype in subjects with diabetic nephropathy was associated with a negative correlation between VD and PTH levels (r = -0.620, P = 0.032) and a positive correlation between VD and FGF23 levels (r = 0.967, P = 0.012). A significant differences in VD levels between patients and controls was observed in the presence of FokI TT (P = 0.044) and CT (P = 0.036) genotypes. The expression of FGF23 serum level was significantly elevated in patients than in controls in the presence of the FokI CC and BsmI AG genotypes. CONCLUSIONS In conclusion, our study shows the existence of an association between VDR FokI, BsmI polymorphisms and mineral status in ESRD patients. The presence of VDR variants affect the protein expression of VD, phosphorus, FGF23 and PTH.
Nephrologie & Therapeutique | 2017
S. Beji; M. Hajji; L. Rais; R. Kheder; H. Jebali; Wided Smaoui; M. Krid; F. Ben Hamida; Lilia Ben Fatma; M.K. Zouaghi
Obstetric cortical renal necrosis is a serious complication that can lead to chronic renal failure and the need for chronic dialysis. The aim of renal cortical necrosis therapy is to restore hemodynamic stability, institute early dialytic therapy, and treat the underlying cause of the disease. Most cases of renal cortical necrosis do not recover a normal renal function despite intensive care. We describe the course of a patient who was diagnosed with acute renal cortical necrosis in pregnancy treated with hemodialysis for three years but then she recovered her renal function.
Nephrologie & Therapeutique | 2016
H. Jebali; Y. Dimassi; L. Ben Fatma; R. Kheder; S. Beji; M. Krid; W. Smaoui; H.F. Ben; L. Rais; M.K. Zouaghi
Nephrologie & Therapeutique | 2016
H. Jebali; Y. Dimassi; S. Azaiz; W. Smaoui; R. Kheder; S. Beji; L. Ben Fatma; H.F. Ben; H. Kateb; L. Rais; M.K. Zouaghi
Nephrologie & Therapeutique | 2016
H. Jebali; N. Sallemi; L. Rais; R. Kheder; H.F. Ben; K. Mzoughi; I. Zairi; Z. Jnifene; S. Kraim; S. Beji; M.K. Zouaghi
Nephrologie & Therapeutique | 2016
H. Jebali; O. Azouz; M. Krid; W. Smaoui; L. Rais; L. Ben Fatma; R. Kheder; H.F. Ben; S. Beji; M.K. Zouaghi
Nephrologie & Therapeutique | 2016
H. Jebali; Y. Dimassi; R. Kheder; L. Rais; W. Smaoui; M.M. Ikrid; H.F. Ben; F.L. Ben; S. Beji; M.K. Zouaghi
Nephrologie & Therapeutique | 2016
Y. Dimassi; H. Jebali; W. Smaoui; S. Azaiz; R. Kheder; L. BenFatma; S. Beji; M. Krid; H. Kateb; F. Benhmida; L. Rais; M.K. Zouaghi
Nephrologie & Therapeutique | 2013
H. Riahi; L. Rais; L. Ben Fatma; W. Smaoui; R. Kheder; M. Krid; S. Beji; F. Ben Hmida; M.K. Zouaghi; F. Ben Moussa
Revue de Médecine Interne | 2018
T. Mesbahi; H. Jebali; Sana Barrah; L. Rais; S. Beji; I. Mami; R. Kheder; M. Krid; W. Smaoui; F. Ben Hamida; L. Ben Fatma; M.K. Zouaghi